Subscribe to RSS
DOI: 10.1055/s-2005-925580
© Georg Thieme Verlag Stuttgart · New York
Stellenwert der Defibrillatortherapie in der Sekundär- und Primärprophylaxe des plötzlichen Herztodes
HerzrhythmusstörungenPublication History
Publication Date:
02 January 2006 (online)
![](https://www.thieme-connect.de/media/notfall-hausarztmedizin/200511/lookinside/thumbnails/10.1055-s-2005-925580-1.jpg)
Zusammenfassung
Die Implantation eines Defibrillators ist Therapie der ersten Wahl bei Patienten, die eine Episode von Kammerflimmern außerhalb eines akuten Herzinfarktes überlebt haben. Bei vielen Patienten besteht aber auch schon vorher eine Indikation, insbesondere bei Patienten, die nach einem Herzinfarkt oder bei einer Herzinsuffizienz eine stark eingeschränkte Auswurffraktion haben. Eine konsequente Umsetzung bestehender Leitlinien in diesem Bereich ermöglicht eine signifikante Verbesserung der Prognose unserer Patienten und ist trotz des relativ hohen Aggregatpreises kosteneffizienter als viele andere Therapien in der modernen Medizin.
Summary
The implantation of a defibrillator is the treatment of choice in patients who have survived ventricular fibrillation outside of an acute myocardial infarction. Many patients, however, have a prior indication, in particular patients who, following an infarction, or who experience cardiac insufficiency, have an appreciably reduced ejection fraction. The rigorous implementation of existing guidelines in this area enables a significant improvement in the prognosis of our patients and, despite the relative high equipment price, is more cost-efficient than many other treatments in modern medicine.
Literatur
- 1 Connolly SJ, Hallstrom AP, Cappato R. et al. . Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J. 2000; 21 2071-2078
- 2 Salukhe TV, Dimopoulos K, Sutton R. et al. . Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications. Circulation. 2004; 109 1848-1853
- 3 Strickberger SA, Hummel JD, Bartlett TG. et al. . Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol. 2003; 41 1707-1712
- 4 The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators . A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997; 337 1576-1583
- 5 Bigger JT Jr. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators . Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med. 1997; 337 1569-1575
- 6 Cleland JG, Daubert JC, Erdmann E. et al. . The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352 1539-1549
- 7 Kuck KH, Cappato R, Siebels J. et al. . Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. 2000; 102 748-754
- 8 Bänsch D, Antz M, Boczor S. et al. . Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation. 2002; 105 1453-1458
- 9 Connolly SJ, Gent M, Roberts RS. et al. . Canadian Implantable Defibrillator Study (CIDS): A Randomized Trial of the Implantable Cardioverter Defibrillator Against Amiodarone. Circulation. 2000; 101 1297-1302
- 10 Bristow MR, Saxon LA, Boehmer J. et al. . Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350 2140-2150
- 11 Kadish A, Dyer A, Daubert JP. et al. . Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004; 350 2151-2158
- 12 Hohnloser SH, Kuck KH, Dorian P. et al. . Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004; 351 2481-2488
- 13 Moss AJ, Zareba W, Hall WJ. et al. . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346 877-883
- 14 Bardy GH, Lee KL, Mark DB. et al. . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352 225-237
Anschrift für die Verfasser
Prof. Dr. Dirk Böcker
Medizinische Klinik und Poliklinik C
Kardiologie und Angiologie-Universitätsklinik Münster
48129 Münster
Phone: 0251-8347617
Fax: 0251-8347864
Email: bockerd@uni-muenster.de